Effect of nebivolol on forearm vasodilation, nitric oxide bioavailability, and oxidative stress in patients with stage 1/2 hypertension.

Trial Profile

Effect of nebivolol on forearm vasodilation, nitric oxide bioavailability, and oxidative stress in patients with stage 1/2 hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2010

At a glance

  • Drugs Metoprolol; Nebivolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 06 Jan 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 06 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top